Selby C., MacNee W. Factors affecting neutrophil transit during acute pulmonary inflammation: minireview. Exp Lung Res1993 ; 19(4): 407-28.
2.
MacNee W., Selby C.New perspectives on basic mechanisms in lung disease. 2. Neutrophil traffic in the lungs: role of haemodynamics, cell adhesion, and deformability . Thorax1993; 48(1): 79-88.
3.
Welbourn CR, Goldman G., Paterson IS, Valeri CR, Shepro D., Hechtman HBPathophysiology of ischaemia reperfusion injury: central role of the neutrophil . Br J Surg1991; 78(6): 651-55.
4.
Welbourn CR, Goldman G., Paterson IS, Valeri CR, Shepro D., Hechtman HBNeutrophil elastase and oxygen radicals: synergism in lung injury after hindlimb ischemia. Am J Physiol1991 ; 260(6 Pt 2): H1852-6.
Sole MJ, Drobac M., Schwartz L., Hussain MN, Vaughan Neil EFThe extraction of circulating catecholamines by the lungs in normal man and in patients with pulmonary hypertension. Circulation1979; 60(1): 160—63.
7.
Moss M., Goodman P., Heinig M., Barkin S., Ackerson L., Parsons P.Establishing the relative accuracy of three new definitions of the adult respiratory distress syndrome. Crit Care Med1995; 23(10): 1629-37.
8.
Murray JF, Matthay MA, Luce JM, Flick MRAn expanded definition of the adult respiratory distress syndrome [published erratum appears in Am Rev Respir Dis 1989; 139(4): 1065]. Am Rev Respir Dis1988; 138(3): 720-23.
9.
Gorin AB, Weidner WJ, Demling RH, Staub NCNoninvasive measurement of pulmonary transvascular protein flux in sheep. J Appl Physiol1978; 45(2): 225-33.
10.
Jones JG, Minty BD, Royston D.The physiology of leaky lungs. Br J Anaesth1982; 54(7): 705-21.
11.
Brigham KL, Kariman K., Harris TR, Snapper JR, Bernard GR, Young SLCorrelation of oxygenation with vascular permeability-surface area but not with lung water in humans with acute respiratory failure and pulmonary edema . J Clin Invest1983; 72(1): 339-49.
12.
Braude S., Nolop KB, Hughes JM, Barnes PJ, Royston D.Comparison of lung vascular and epithelial permeability indices in the adult respiratory distress syndrome. Am Rev Respir Dis1986; 133(6): 1002-1005.
13.
Mason GR, Effros RM, Uszler JM, Mena I.Small solute clearance from the lungs of patients with cardiogenic and noncardiogenic pulmonary edema. Chest1985; 88(3): 327-34.
14.
Rocker GM, Wiseman MS, Pearson D., Shale DJDiagnostic criteria for adult respiratory distress syndrome: time for reappraisal [published erratum appears in Lancet 1989; i: 342]. Lancet1989; i: 120-23.
15.
Royston D., Braude S., Nolop KBFailure of aerosolised 99mTc DTPA clearance to predict outcome in patients with adult respiratory distress syndrome. Thorax1987; 42(7): 494-99.
16.
Rinaldo JE, Borovetz HS, Mancini MC, Hardesty RL, Griffith BPAssessment of lung injury in the adult respiratory distress syndrome using multiple indicator dilution curves. Am Rev Respir Dis1986; 133(6): 1006-10.
17.
Rinaldo JE, Pennock B.Effects of ibuprofen on endotoxin-induced alveolitis: biphasic dose response and dissociation between inflammation and hypoxemia. Am J Med Sci1986; 291(1): 29-38.
18.
Royston D., Minty BD, Higenbottam TW, Wallwork J., Jones GJThe effect of surgery with cardiopulmonary bypass on alveolar-capillary barrier function in human beings. Ann Thorac Surg1985; 40(2): 139-43.
19.
Macnaughton PD, Braude S., Hunter DN, Denison DM, Evans TWChanges in lung function and pulmonary capillary permeability after cardiopulmonary bypass . Crit Care Med1992; 20(9): 1289-94.
20.
Westbrook PR , Stubbs SE, Sessler AD, Rehder K., Hyatt REEffects of anesthesia and muscle paralysis on respiratory mechanics in normal man. J Appl Physiol1973; 34(1): 81-86.
21.
Kollef MH, Peller T., Knodel A., Cragun WHDelayed pleuropulmonary complications following coronary artery revascularization with the internal mammary artery. Chest1988 ; 94(1): 68-71.
22.
Ellison LT, Duke JF, Ellison RGPulmonary compliance following open-heart surgery and its relationship to ventilation and gas exchange. Circulation1967; 35(4 suppl): 1217-25.
23.
Wilcox P., Baile EM, Hards J. et al. Phrenic nerve function and its relationship to atelectasis after coronary artery bypass surgery. Chest1988 ; 93(4): 693-98.
24.
Svennevig JL , Geiran OR, Karlsen H. et al. Complement activation during extracorporeal circulation. In vitro comparison of Duraflo II heparin-coated and uncoated oxygenator circuits. J Thorac Cardiovasc Surg1993; 106(3): 466-72.
25.
Gu YJ, van Oeveren W., Akkerman C., Boonstra PW, Huyzen RJ, Wildevuur CRHeparin-coated circuits reduce the inflammatory response to cardiopulmonary bypass. Ann Thorac Surg1993; 55(4): 917-22.
26.
Borowiec JW , Bylock A., van der Linden J., Thelin S.Heparin coating reduces blood cell adhesion to arterial filters during coronary bypass: a clinical study. Ann Thorac Surg1993; 55(6): 1540-45.
27.
Francalancia NA, Aeba R., Yousem SA, Griffith BP, Marrone GCDeleterious effects of cardiopulmonary bypass on early graft function after single lung allotransplantation: evaluation of a heparin-coated bypass circuit. J Heart Lung Transplant1994; 13(3): 498-507.
Royston D.Aprotinin therapy in heart and heart-lung transplantation. J Heart Lung Transplant1993; 12(1)(Pt 1): S19-25.
30.
Royston D.High-dose aprotinin therapy: a review of the first five years' experience . J Cardiothorac Vasc Anesth1992; 6(1): 76-100.
31.
Christopherson R., Beattie C., Frank SM et al. Perioperative morbidity in patients randomized to epidural or general anesthesia for lower extremity vascular surgery. Perioperative Ischemia Randomized Anesthesia Trial Study Group. Anesthesiology1993; 79(3): 422-34.
32.
Liem TH, Hasenbos MA, Booij LH, Gielen MJCoronary artery bypass grafting using two different anesthetic techniques: Part 2: Postoperative outcome. J Cardiothorac Vasc Anesth1992; 6(2): 156-61.
33.
Liu S., Carpenter R., Neal J.Epidural anesthesia and analgesia: Their role in postoperative outcome. Anesthesiology1995; 82(6): 1474-506.
34.
Breslow MJ, Parker SD, Frank SM et al. Determinants of catecholamine and cortisol responses to lower extremity revascularization. The PIRAT Study Group. Anesthesiology1993; 79(6): 1202-1209.
35.
Liem TH, Booij LH, Gielen MJ, Hasenbos MA, van Egmond J.Coronary artery bypass grafting using two different anesthetic techniques: Part 3: Adrenergic responses. J Cardiothorac Vasc Anesth1992; 6(2): 162-67.
36.
Stenseth R., Bjella L., Berg EM, Christensen O., Levang OW, Gisvold SEThoracic epidural analgesia in aortocoronary bypass surgery. II: Effects on the endocrine metabolic response. Acta Anaesthesiol Scand1994; 38(8): 834-39.
37.
Enson Y.Pulmonary heart disease: relation of pulmonary hypertension to abnormal lung structure and function. Bull NY Acad Med1977 ; 53(6): 551-66.
38.
Lowenstein E., Johnson WE, Lappas DG et al. Catastrophic pulmonary vasoconstriction associated with protamine reversal of heparin. Anesthesiology1983; 59(5): 470-73.
39.
D'Ambra MN, LaRaia PJ, Philbin DM, Watkins WD, Hilgenberg AD, Buckley MJProstaglandin E1. A new therapy for refractory right heart failure and pulmonary hypertension after mitral valve replacement. J Thorac Cardiovasc Surg1985; 89(4): 567-72.
40.
DeFeudis FVMechanism of endothelium-dependent vasorelaxation . Med Hypotheses1985; 17(4): 363-74.
41.
Thom SA, Hughes AD, Martin GN, Sever PSThe release of the endothelium derived relaxing factor from isolated human arteries. J Hypertens Suppl1985; 3(Suppl 3): S97-9.
42.
Albright RL , Babett JAPoisonous effects of the impurities of nitrous oxide. J Oral Surg1968; 26(10): 643-45.
43.
Clutton Brock J.Two cases of poisoning by contamination of nitrous oxide with higher oxides of nitrogen during anaesthesia. Br J Anaesth1967; 39(5): 388-92.
44.
Borland C., Higenbottam T.Do the oxides of nitrogen in cigarette smoke cause emphysema in smokers ? Tokai J Exp Clin Med1985; 10(4): 371-73.
45.
Bindl L., Fahnenstich H., Peukert U.Aerosolised prostacyclin for pulmonary hypertension in neonates. Arch Dis Child Fetal Neonatal Ed1994; 71(3): F214-6.
46.
Pappert D., Busch T., Gerlach H., Lewandowski K., Radermacher P., Rossaint R.Aerosolized prostacyclin versus inhaled nitric oxide in children with severe acute respiratory distress syndrome. Anesthesiology1995; 82(6): 1507-11.
47.
Sitbon O., Brenot F., Denjean A. et al. Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension. A dose-response study and comparison with prostacyclin . Am J Respir Crit Care Med1995; 151(2 Pt 1): 384-9.
48.
Walmrath D. , Schneider T., Pilch J., Grimminger F., Seeger W.Aerosolised prostacyclin in adult respiratory distress syndrome. Lancet1993; 342(8877): 961-62.
49.
Zwissler B. , Welte M., Messmer K.Effects of inhaled prostacyclin as compared with inhaled nitric oxide on right ventricular performance in hypoxic pulmonary vasoconstriction. J Cardiothorac Vasc Anesth1995; 9(3): 283-89.
50.
Zwissler B. , Rank N., Jaenicke U. et al. Selective pulmonary vasodilation by inhaled prostacyclin in a newborn with congenital heart disease and cardiopulmonary bypass. Anesthesiology1995; 82(6): 1512-16.
51.
Walmrath D. , Schneider T., Pilch J., Schermuly R., Grimminger F., Seeger W.Effects of aerosolized prostacyclin in severe pneumonia. Impact of fibrosis. Am J Respir Crit Care Med1995; 151(3 Pt 1): 724-30.
52.
Royston D.Inhalational agents for pulmonary hypertension. Lancet1993; 342(8877): 941-42.
53.
Salvemini D. , Pistelli A., Mollace V.Release of nitric oxide from glyceryl trinitrate by captopril but not enalaprilat: in vitro and in vivo studies. Br J Pharmacol1993; 109(2): 430-36.